“Compared to adults, children with type 2 diabetes have limited treatment options, even though the disease and symptom onset generally progress more rapidly in children,”
The FDA has approved Jardiance (empagliflozin) and Synjardy (empagliflozin and metformin hydrochloride) as additions to diet and exercise to improve blood sugar control in children 10 years and older with type 2 diabetes.
Read the full story here:
https://lnkd.in/dXtAR_ME
#diabetes #diabetesmanagement #diabetescare
Let’s put a face to a name! Let us introduce you to one of the “pillars” of our organisation, our
Come and meet us at Expopharm 2023! 27 -30 September in DÜSSELDORF. Our colleagues Luca Schincaglia and Marco Ferrario will
The campaign theme for World Alzheimer’s Month 2023 is ‘Never too early never too late’. The ‘Never too early, never
Today is the day! Elixi International is going to Singapore! Today we are thrilled to announce the opening of our
Elixi International SA
Vicolo Oldelli 12
6830 Chiasso (TI)
Switzerland
Elixi Pharma pte. ltd.
6A Shenton way #04-01
Downtown gallery building
Singapore
